mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |